Bit.bio expands portfolio targeting neurological conditions
It's products will target neurological diseases such as epilepsy, schizophrenia, autism and Alzheimer’s.
Study is first step towards blood-based screening tool for Alzheimer’s
Researchers are working on identifying immune deficits that are associated with the development of the disease.
New novel drug delivery method has potential to treat Alzheimer’s
Japanese scientists have developed a novel drug delivery framework which [...]
Nuvance pilots remote monitoring tech to support patients with MCI
Neurologists are testing a remote monitoring programme to support patients with mild cognitive impairment at home.
Trualta offers free education to families caring for loved ones
The e-learning platform has partnered with Washington State University to provide free education.
FDA gives go ahead to Neurosteer brain monitoring platform
The technology can aid in the early detection of Alzheimer's and Parkinson's disease
Poor diet in mid-30s can increase Alzheimer’s risk
Having high cholesterol and blood sugar in your mid-30s may [...]
Studies reveal gut bacteria role in Alzheimer’s development
Gut health plays a significant role in the development of [...]
Alzheimer’s blood test up to 93% accurate
A new blood test for detecting early signs of Alzheimer’s [...]
Memory sequencing find paves the way for Alzheimer’s breakthrough
Research in the US has revealed how the brain organises [...]
